Announcements
Projects
Orgs
Project Post
Articles 81
Votes 1
0% interested
Targetedonc.com

Authors 48

Conor Killmurray
Alan Bryce
MD
Eleni Efstathiou
Daniel Landau
Adam Weiner
William J. Gradishar
Tony Berberabe
MPH
Jordyn Sava
Naveen Pemmaraju
Ariana Pelosci
Kristie L. Kahl
Cristian Tomasetti
PhD
Aditya Bardia
Nichole Tucker
Targeted Oncology Staff
Lisa Astor
John E. Sylvester
Dylann Cohn-Emery
Luis E. Raez
John M. Burke
Lauren Bollinger
Russ Conroy
Laura Dawson
Kristi Rosa
David O'Malley
Nicholas J. Robert
Bruno Lemos
Jennifer Gass
FACMG
Jonah Feldman
Skye Montoya
Tara Seery
Ritu Salani
Chad A. Hamilton
Pallawi Torka
Crystal Ritchey
Naomi G. Dempsey
Ruchi Garg
Morgan Bayer
Sabrina Serani
Mark A. Davis
MS
Joshua Richter
Nasir Chaudry
Sara A. Hurvitz
DLBCL in Older Adults: Applying the Goldilocks Principle - Targeted Oncology
almost2y
Recent Data Updates from PRIMA and PAOLA-1 Trials in Ovarian Cancer - Targeted Oncology
almost2y
Improving Outcomes in All Ovarian Cancer Subtypes - Targeted Oncology
almost2y
Clinical Pearls and Future Directions of Cervical Cancer Treatment - Targeted Oncology
almost2y
Next Steps for Novel Treatment Combination in Pancreatic Cancer - Targeted Oncology
~2y
Orca-T Leads to High RFS Rates in Acute Leukemias and MDS - OncLive
>2y
Cholangiocarcinoma Awareness Day: Advances in Frontline and Later BTC Therapies - Targeted Oncology
>2y
FDA Places Partial Clinical Hold on Phase 1/2 VELA Trial of BLU-222 in Solid Tumors - Targeted Oncology
>2y
Roundtable Discussion: Examining the Challenges of Hedgehog Pathway Inhibitors and Immunotherapy in Basal Cell Carcinoma - Targeted Oncology
>2y
Durable Response Seen With PD-1 Plus BRAF/MEK Inhibitor Combo in CRC - Targeted Oncology
>2y
Breaking Down Resistance to BTK Inhibitors - Targeted Oncology
>2y
Precision Oncology Inches into Head and Neck Cancer Paradigm - Targeted Oncology
>2y
Present and Future Precision Medications Signal Promise for Adults With Glioma - Targeted Oncology
>2y
World Cancer Day: Next Generation Sequencing at the Forefront of Precision Medicine - Targeted Oncology
>2y
Main Takeaways From the MYLUNG Study in mNSCLC - Targeted Oncology
>2y
Mirvetuximab Soravtansine Proves Safe and Effective in FRĪ±-High Ovarian Cancer - Targeted Oncology
>2y
Discussing Phase 1 Findings of Ubamatamab in the Ovarian Cancer Space - Targeted Oncology
>2y
Trifluridine/Tipiracil Plus Bevacizumab Improves OS in Refractory Metastatic Colorectal Cancer - www.oncnursingnews.com/
>2y
Yu Highlights Possible Sequencing Strategies in mCRPC - Targeted Oncology
>2y
Adding Bevacizumab to Trifluridine/Tipiracil Boosts Survival, Disease Control Rate in mCRC - Targeted Oncology
>2y
Adding Veliparib or Pembrolizumab to Neoadjuvant Chemoradiation Not Beneficial for Locally Advanced Rectal Cancer - Targeted Oncology
>2y
Results From the Phase 3 NRG/RTOG 1112 Study of Sorafenib in HCC - Targeted Oncology
>2y
Addressing Patient Subgroups Is a Key Topic During Breast Cancer Conference - Targeted Oncology
>2y
Tremelimumab Plus Durvalumab Shows Promising Activity, Safety in Gastric/GEJ Adenocarcinoma - Targeted Oncology
>2y
Dostarlimab Benefit Confirmed for Patients with MRD, Locally Advanced Rectal Cancer - Targeted Oncology
>2y